• <blockquote id="kzik6"></blockquote>
    <blockquote id="kzik6"></blockquote>

    
日本久久99成人网站,在线观看美女网站大全免费,亚洲制服另类无码专区,看国产黄大片在线观看,欧美屁股大的xxxxx,精品国产av色欲果冻传媒,最近中文字幕完整国语,国产精品18久久久久久麻辣 




    
    
    
        
    
            
    您好！歡迎訪問上海起發實驗試劑有限公司網站！
    
            
        
    
    
    
    
    
        
    
            
            
    
                全國服務咨詢熱線:
                
    15921799099
    
            
    
        
    
    
    

    
    

    


    





    







    
    
    
        
    當前位置：首頁 > 資料下載 > ipatherapeutics 2026年終端采購售價清單-上海起發
    
    
    
    
    
    
    	
    
        	
            
    ipatherapeutics 2026年終端采購售價清單-上海起發
    
            
    發布時間：2025/12/19      點擊次數：372
    
            
    
                
    荷蘭ipatherapeutics生物公司是ImmunoPrecise Antibodies Ltd.（NASDAQ: IPA）旗下的重要品牌，是一家在生物治療領域具有影響力的合同研究組織。公司成立于1989年，總部位于美國法戈，并在北美和歐洲設有多個分支機構，員工規模在51至200人之間。該公司專注于抗體發現與開發服務，致力于通過融合生物技術和人工智能技術推動生物治療創新。
    ipatherapeutics的核心技術平臺包括其獨特的B細胞選擇®兔單克隆抗體技術、轉基因動物模型以及多通道膜蛋白靶向抗體平臺。兔免疫系統的優勢在于能產生高特異性和高親和力抗體，結合公司功能優先的B細胞選擇工作流程，可在早期識別出優秀的診斷抗體面板。其轉基因動物模型能夠針對小于3 kDa的小分子和具有復雜二級結構的蛋白質生成大量序列多樣、生物學相關的候選抗體。在多通道膜蛋白靶向抗體方面，公司通過BLI平臺進行特異性測試，結合抗體面板的親和力排名或表位映射和分箱，實現分子質量優化。
    公司近年來積極整合人工智能技術，特別是其LENSai™計算軟件平臺和HYFT技術，通過多組學建模和復雜的人工智能系統支持抗體發現過程。2023年，公司通過收購BioStrand獲得了一套基于云的革命性解決方案，能夠加速多組學研究數據分析。此外，公司的OmniChicken®發現平臺是行業內成功改造的鳥類平臺，具有能夠產生人類序列抗體庫的免疫系統。
    ipatherapeutics提供抗體開發服務，涵蓋從定制單克隆和多克隆抗體開發、抗體工程與優化到抗體生產和純化的完整流程。公司服務對象包括制藥公司、生物技術企業、研究機構和學術界客戶。其產品線涵蓋多種研究用抗體，包括針對各種疾病靶點的單克隆抗體，例如貨號MQ13.101的鼠標抗瓜氨酸纖維蛋白原抗體和貨號MQR2.201的人抗凋亡 cleavage product of human U1-70K抗體等。
    公司將自身定位為“生物治療智能的中心"，通過結合專業知識和技術，為制藥合作伙伴提供高度專業化的全連續治療性抗體發現、開發和對外許可服務。公司的使命是為制藥客戶提供智能和技術來治療疾病，目標是提高生物治療的特異性。

    關鍵詞：ipatherapeutics，ipatherapeutics上海代理，ipatherapeutics中國代理，ipatherapeutics北京代理，ipatherapeutics江蘇代理， ipatherapeutics廣東代理,N002-100ML, N001-0.5mg, N001-0.1mg, R001-100ML, L101-0.025mg immunoprecise u-proteinexpress、ipatherapeutics、免疫精確抗體、IPA生物治療、B細胞選擇兔單克隆抗體、人工智能抗體發現、LENSai平臺、OmniChicken技術、轉基因動物模型、多通道膜蛋白靶向、抗體發現服務、生物治療智能、定制抗體開發、HYFT技術、治療性抗體、生物制藥研發、GPCR抗體、結構生物學、抗體人源化、生物標記物發現、臨床前開發。

    特別告知：為保證產品質量與良好性能，所以在購買相應產品的同時我司會收取一定量的運輸費用！！！本次報價有效時間為2025年12月19日---2026年12月20日。
    （*此為部分產品價格,完整價格請下載文件)
    貨號
    品名
    規格
    價格
    品牌
    N001-0.1 mg
    WNT Surrogate-Fc Fusion Protein
    100µg
    17641.8
    ipatherapeutics
    N001-0.5 mg
    WNT Surrogate-Fc Fusion Protein
    500µg
    70270.2
    ipatherapeutics
    N001-1.0 mg
    WNT Surrogate-Fc Fusion Protein
    1mg
    105454.8
    ipatherapeutics
    N002-100 ml
    Noggin-Fc Fusion Protein Conditioned Medium
    100ml
    24690.6
    ipatherapeutics
    N002-200 ml
    Noggin-Fc Fusion Protein Conditioned Medium
    200ml
    44569.8
    ipatherapeutics
    N002-500 ml
    Noggin-Fc Fusion Protein Conditioned Medium
    500ml
    64548
    ipatherapeutics
    O001
    OIT1, Murine
    100ug
    9603
    ipatherapeutics
    P001
    Platelet Derived Growth Factor Βeta, Human
    100ug
    9999
    ipatherapeutics
    P002
    PDGF-R Beta-(His)C, ECD, Human, Recombinant
    100ug
    10711.8
    ipatherapeutics
    R001-100 ml
    Rspo3-Fc Fusion Protein Conditioned Medium
    100ml
    24690.6
    ipatherapeutics
    R001-200 ml
    Rspo3-Fc Fusion Protein Conditioned Medium
    200ml
    44569.8
    ipatherapeutics
    R001-500 ml
    Rspo3-Fc Fusion Protein Conditioned Medium
    500ml
    64548
    ipatherapeutics
    R002-0.1 mg
    mRSPO1-Fc
    0.1mg
    9801
    ipatherapeutics
    R002-0.5 mg
    mRSPO1-Fc
    0.5mg
    38966.4
    ipatherapeutics
    R002-1.0 mg
    mRSPO1-Fc
    1.0mg
    58429.8
    ipatherapeutics
    R005-0.1 mg
    mRSPO1-his
    0.1mg
    9801
    ipatherapeutics
    R005-0.5 mg
    mRSPO1-his
    0.5mg
    38966.4
    ipatherapeutics
    R005-1.0 mg
    mRSPO1-his
    1.0mg
    58429.8
    ipatherapeutics
    R006-0.1 mg
    hRSPO1-Fc
    0.1mg
    9801
    ipatherapeutics
    R006-0.5 mg
    hRSPO1-Fc
    0.5mg
    38966.4
    ipatherapeutics
    R006-1.0 mg
    hRSPO1-Fc
    1.0mg
    58429.8
    ipatherapeutics
    R006-2.0 mg
    hRSPO1-Fc
    2.0mg
    88723.8
    ipatherapeutics
    R007-0.1 mg
    hRSPO1-his
    0.1mg
    9801
    ipatherapeutics
    R007-0.5 mg
    hRSPO1-his
    0.5mg
    38966.4
    ipatherapeutics
    R007-1.0 mg
    hRSPO1-his
    1.0mg
    58429.8
    ipatherapeutics
    R009-10 ml
    enhanced Rspo3-Fc Fusion Protein Conditioned Medium
    10ml
    24472.8
    ipatherapeutics
    R009-50 ml
    enhanced Rspo3-Fc Fusion Protein Conditioned Medium
    50ml
    97891.2
    ipatherapeutics
    R010-0.1 mg
    enhanced Rspo3-Fc Fusion Protein
    0.1mg
    24472.8
    ipatherapeutics
    R010-0.5 mg
    enhanced Rspo3-Fc Fusion Protein
    0.5mg
    97891.2
    ipatherapeutics
    S001
    Sp-D, Porcine
    100ug
    9603
    ipatherapeutics
    S002
    Sp-D, Human
    100ug
    9603
    ipatherapeutics
    S003A
    Syndecan-1-(His)C, Human, Recombinant, higher glycosylation than S003B
    100µg
    10098
    ipatherapeutics
    S003B
    Syndecan-1-(His)C, Human, Recombinant, lower glycosylation than S003A
    100µg
    10098
    ipatherapeutics
    T004
    Tev Protease
    1mg
    18255.6
    ipatherapeutics
    T005
    TFPI-Alpha-(His)C, Human, Recombinant
    100µg
    11226.6
    ipatherapeutics
    T006
    Thrombomodulin-(Tev-His)N, Human, Recombinant
    100µg
    11226.6
    ipatherapeutics
    U001
    Upar-(His)N, Human, Recombinant
    100ug
    10098
    ipatherapeutics
    V001
    vWF-A1 Domain, Human, Residues 1261-1468
    100ug
    8375.4
    ipatherapeutics
    V002
    vWF-A1 Domain, Human, Residues 1261-1468, VWD Type 2B, Recombinant
    100ug
    8989.2
    ipatherapeutics
    V003
    vWF-A1 Domain, Human, Residues 1238-1481, Glycosylated
    100ug
    10711.8
    ipatherapeutics
    V004
    vWF-A3 Domain, Human, Residues 1683-1874, Recombinant
    100ug
    9603
    ipatherapeutics
    V005
    vWF-A3 Domain, Human, Residues 1683-1874, without Tag, Recombinant
    100ug
    10197
    ipatherapeutics
    V010
    VCAM1-(His)N, Transcript A, Human, Recombinant
    100ug
    11226.6
    ipatherapeutics
    V011
    vWF-A1-A2-A3-(his)C domain, Human, Residues 1261-1874, Recombinant
    100µg
    13068
    ipatherapeutics
    V012
    vWF-A1-A2-A3-R1597Q-(his)C domain, Human, Residues 
    1261-1874, Recombinant
    100µg
    13068
    ipatherapeutics
    PODI-0005
    mouse anti-barley LTP
    100ug
    8375.4
    ipatherapeutics
    PODI-0006
    mouse anti-human ACTH (POMC)
    100ug
    8375.4
    ipatherapeutics
    PODI-0007
    mouse anti-rabbit uteroglobuline
    100ug
    8375.4
    ipatherapeutics
    PODI-0008
    mouse anti-Trichinella spiralis
    100ug
    8375.4
    ipatherapeutics
    PODI-0009
    mouse anti-Leptospira interogans OMP (2D1D7)
    100ug
    8375.4
    ipatherapeutics
    PODI-0011
    mouse anti-Cowdria ruminantium OMP (1E5H8)
    100ug
    8375.4
    ipatherapeutics
    PODI-0012
    mouse anti-Cowdria ruminantium OMP (4F10B4) 
    100ug
    8375.4
    ipatherapeutics
    PODI-0013
    mouse anti-human HSP60, specific for eukaryotic HSP60
    100ug
    8375.4
    ipatherapeutics
    PODI-0014
    mouse anti-human HSP60, specific for eukaryotic and prokaryotic HSP60
    100ug
    8375.4
    ipatherapeutics
    PODI-0015
    mouse anti-HSP70, cross reactive with E.coli DNAK
    100ug
    8375.4
    ipatherapeutics
    PODI-0016
    mouse anti-sheep IgE
    100ug
    8375.4
    ipatherapeutics
    PODI-0017
    mouse anti-rat gonocytes
    100ug
    8375.4
    ipatherapeutics
    PODI-0018
    mouse anti-chloroamphenicol
    100ug
    8375.4
    ipatherapeutics
    PODI-0019
    mouse anti-human PLK1
    100ug
    8375.4
    ipatherapeutics
    PODI-0023
    mouse anti-human PBDK1
    100ug
    8375.4
    ipatherapeutics
    PODI-0027
    mouse anti-human PBDK2
    100ug
    8375.4
    ipatherapeutics
    PODI-0031
    mouse anti-human Mps1
    100ug
    8375.4
    ipatherapeutics
    PODI-0034
    mouse anti-GFP
    100ug
    8375.4
    ipatherapeutics
    PODI-0035
    mouse anti-human MASP-2
    100ug
    8375.4
    ipatherapeutics
    PODI-0037
    mouse anti-human FAM3D
    100ug
    8375.4
    ipatherapeutics
    PODI-0038
    mouse anti-human FAM3D, cross reacts with mouse Oit-1
    100ug
    8375.4
    ipatherapeutics
    PODI-0039
    mouse anti-human MBL-2
    100ug
    8375.4
    ipatherapeutics
    PODI-0040
    human Placental Alkaline Phosphatase (2B4H11)
    100ug
    8375.4
    ipatherapeutics
    PODI-0042
    human Placental Alkaline Phosphatase (23F4G3)
    100ug
    8375.4
    ipatherapeutics
    PODI-0043
    human Intestinal Alkaline Phosphatase (8A8E3)
    100ug
    8375.4
    ipatherapeutics
    PODI-0058
    mouse anti-rat CD40
    100ug
    8375.4
    ipatherapeutics
    PODI-0059
    mouse anti-Ovalbumin
    100ug
    8375.4
    ipatherapeutics
    PODI-0061
    mouse anti-Neisseria meningitidis Omp85 (32F9)
    100ug
    8375.4
    ipatherapeutics
    PODI-0063
    mouse anti-Lactobacillus rhamnosus SpaC
    100ug
    8375.4
    ipatherapeutics
    PODI-0064
    mouse anti-Streptococcus pneumonia PspA
    100ug
    8375.4
    ipatherapeutics
    PODI-0065
    mouse anti-human PDGF
    100ug
    8375.4
    ipatherapeutics
    PODI-0068
    mouse anti-human CD36, cross reacts with dog
    100ug
    8375.4
    ipatherapeutics
    PODI-0069
    mouse anti-STREP-II tag
    100ug
    8375.4
    ipatherapeutics
    PODI-0070
    mouse anti-human Mart-1, IHC on melanoma tissue
    100ug
    8375.4
    ipatherapeutics
    PODI-0071
    mouse anti-human BCHE
    100ug
    8375.4
    ipatherapeutics
    PODI-0073
    mouse anti-human IGFBP-7
    100ug
    8375.4
    ipatherapeutics
    PODI-0076
    mouse anti-Neisseria meningitidis Omp85
    100ug
    8375.4
    ipatherapeutics
    PODI-0077
    mouse anti-N-terminal-His tag
    100ug
    8375.4
    ipatherapeutics
    PODI-0079
    human Intestinal Alkaline Phosphatase, detector antibody in
     ELISA with 8A8E3
    100ug
    8375.4
    ipatherapeutics
    PODI-0080
    mouse anti-human Factor V
    100ug
    8375.4
    ipatherapeutics
    PODI-0081
    mouse anti-human PKM2
    100ug
    8375.4
    ipatherapeutics
    PODI-0082
    mouse anti-human CD63
    100ug
    8375.4
    ipatherapeutics
    PODI-0083
    mouse anti-human CD31
    100ug
    8375.4
    ipatherapeutics
    PODI-0084
    mouse anti-human CD41
    100ug
    8375.4
    ipatherapeutics
    PODI-0085
    mouse anti-human CD61
    100ug
    8375.4
    ipatherapeutics
    PODI-0086
    mouse anti-human CD42B
    100ug
    8375.4
    ipatherapeutics
    PODI-0087
    mouse anti-human vWF
    100ug
    8375.4
    ipatherapeutics
    PODI-0088
    mouse anti-Thrombospondin
    100ug
    8375.4
    ipatherapeutics
    PODI-0089
    mouse anti-Annexin-5
    100ug
    8375.4
    ipatherapeutics
    PODI-0090
    mouse anti-human Protein S
    100ug
    8375.4
    ipatherapeutics
    PODI-0091
    mouse anti-CD40 (8B9)
    100ug
    8375.4
    ipatherapeutics
    PODI-0092
    mouse anti-CD40 (16B4E4)
    100ug
    8375.4
    ipatherapeutics
    PODI-0093
    mouse anti-NY-ESO
    100ug
    8375.4
    ipatherapeutics


     
    
        		
     文件下載    
    
            
    
            
            
            
        
    
    
    


    




    
    
    
        
    
            
    
                
    
                    
    上海起發實驗試劑有限公司
    
                    
    地址：上海浦東川沙鎮川沙路6619號上海起發實驗試劑有限公司
    
                    
    郵箱：xs1@78bio.com
    
                    
    傳真：021-50724961
    
                
    
                
                
    
                    
    關注我們
    
                    
    歡迎您關注我們的微信公眾號了解更多信息：
    
                    
    
                        
    
                        
    歡迎您關注我們的微信公眾號
    了解更多信息